Side-by-side comparison of AI visibility scores, market position, and capabilities
AI bioprocessing data platform for cellular agriculture and synthetic biology optimizing fermentation with 90% data reduction; $20.6M raised at $5M revenue serving industrial biotech scale-up.
Invert is a San Francisco-based AI software company providing data analytics and process optimization infrastructure for biomanufacturing — enabling bioprocessing teams at cellular agriculture, synthetic biology, and industrial biotech companies to manage, analyze, and optimize their bioprocess data in real-time. Founded and backed with $20.6 million raised, Invert generates $5 million in revenue and employs 40 people, applying meta-learning approaches that reportedly reduce new data requirements for process optimization by up to 90%.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.